Ohio Mesothelioma Doctors, Cancer Centers and Treatment

Mesothelioma patients who live in Ohio have access to quality mesothelioma treatment options in state. Conventional mesothelioma treatments available in Ohio include surgery, chemotherapy, and radiation. Beyond these conventional treatments, clinical trials may currently be recruiting pleural and peritoneal mesothelioma patients in Ohio.

We provide a list of top mesothelioma doctors that practice in Ohio as well as the top cancer care centers in the state. A list of local cancer support services has been included as well for your convenience. Learn more about health care options available in Ohio below.

Find a Mesothelioma Cancer Center in Ohio

The following mesothelioma cancer centers are located in the state of Ohio. These cancer centers are equipped to deliver quality mesothelioma treatment. Click on a specific cancer center link to get more in depth information.

Find a Mesothelioma Doctor in Ohio

For your convenience, we have compiled a list of mesothelioma doctors that are located in Ohio. Please click on a doctor link to obtain more information about their background, areas of expertise, professional affiliations, and contact information.

It is not uncommon for patients to travel outside of their current states to meet with top oncologists and thoracic surgeons across the country. These mesothelioma experts usually have a particular focus within their practice.

Mesothelioma Clinical Trials in Ohio

The following clinical trials are in progress or actively recruiting participants in the state of Ohio:

• Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

  Conditions:	Acinar Cell Carcinoma; Adenoid Cystic Carcinoma; Adrenal Cortex Carcinoma; Adrenal Gland Pheochromocytoma; Anal Canal Neuroendocrine Carcinoma; Anal Canal Undifferentiated Carcinoma; Angiosarcoma; Apocrine Neoplasm; Appendix Mucinous Adenocarcinoma; Bartholin Gland Transitional Cell Carcinoma; Basal Cell Carcinoma; Bladder Adenocarcinoma; Cervical Adenocarcinoma; Cervical Clear Cell Adenocarcinoma; Cholangiocarcinoma; Chordoma; Colorectal Squamous Cell Carcinoma; Desmoid-Type Fibromatosis; Endometrial Transitional Cell Carcinoma; Endometrioid Adenocarcinoma; Esophageal Neuroendocrine Carcinoma; Esophageal Undifferentiated Carcinoma; Extrahepatic Bile Duct Carcinoma; Extramammary Paget Disease; Fallopian Tube Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Fibromyxoid Tumor; Gallbladder Carcinoma; Gastric Neuroendocrine Carcinoma; Gastric Squamous Cell Carcinoma; Gastric Undifferentiated Carcinoma; Gastrointestinal Stromal Tumor; Gestational Trophoblastic Tumor; Giant Cell Carcinoma; Intestinal Neuroendocrine Carcinoma; Intrahepatic Cholangiocarcinoma; Lung Carcinoid Tumor; Lung Sarcomatoid Carcinoma; Major Salivary Gland Carcinoma; Malignant Odontogenic Neoplasm; Malignant Peripheral Nerve Sheath Tumor; Malignant Testicular Sex Cord-Stromal Tumor; Metaplastic Breast Carcinoma; Metastatic Malignant Neoplasm of Unknown Primary; Minimally Invasive Lung Adenocarcinoma; Mixed Mesodermal (Mullerian) Tumor; Mucinous Adenocarcinoma; Mucinous Cystadenocarcinoma; Nasal Cavity Adenocarcinoma; Nasal Cavity Carcinoma; Nasopharyngeal Carcinoma; Nasopharyngeal Papillary Adenocarcinoma; Nasopharyngeal Undifferentiated Carcinoma; Oral Cavity Carcinoma; Oropharyngeal Undifferentiated Carcinoma; Ovarian Adenocarcinoma; Ovarian Clear Cell Adenocarcinoma; Ovarian Germ Cell Tumor; Ovarian Mucinous Adenocarcinoma; Ovarian Squamous Cell Carcinoma; Ovarian Transitional Cell Carcinoma; Pancreatic Acinar Cell Carcinoma; Pancreatic Neuroendocrine Carcinoma; Paraganglioma; Paranasal Sinus Adenocarcinoma; Paranasal Sinus Carcinoma; Parathyroid Gland Carcinoma; PEComa; Peritoneal Mesothelioma; Pituitary Gland Carcinoma; Placental Choriocarcinoma; Primary Peritoneal High Grade Serous Adenocarcinoma; Pseudomyxoma Peritonei; Rare Disorder; Scrotal Squamous Cell Carcinoma; Seminal Vesicle Adenocarcinoma; Seminoma; Serous Cystadenocarcinoma; Small Intestinal Adenocarcinoma; Small Intestinal Squamous Cell Carcinoma; Solid Neoplasm; Spindle Cell Neoplasm; Squamous Cell Carcinoma of the Penis; Teratoma With Somatic-Type Malignancy; Testicular Non-Seminomatous Germ Cell Tumor; Thyroid Gland Carcinoma; Tracheal Carcinoma; Transitional Cell Carcinoma; Ureter Adenocarcinoma; Ureter Squamous Cell Carcinoma; Urethral Adenocarcinoma; Urethral Squamous Cell Carcinoma; Vaginal Adenocarcinoma; Vaginal Squamous Cell Carcinoma, Not Otherwise Specified; Vulvar Carcinoma
  Last Updated:	July 8, 2019
  Status:	Recruiting
  Locations:	Beavercreek, OH. Belpre, OH. Boardman, OH. Canton, OH. Centerville, OH. Chillicothe, OH. Cincinnati, OH. Cleveland, OH. Columbus, OH. Dayton, OH.

• Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma

  Conditions:	Biphasic Mesothelioma; Epithelioid Mesothelioma; Stage I Pleural Malignant Mesothelioma AJCC v7; Stage IA Pleural Malignant Mesothelioma AJCC v7; Stage IB Pleural Malignant Mesothelioma AJCC v7; Stage II Pleural Malignant Mesothelioma AJCC v7; Stage III Pleural Malignant Mesothelioma AJCC v7
  Last Updated:	July 4, 2019
  Status:	Recruiting
  Locations:	Cincinnati, OH. Phoenix, AZ. Scottsdale, AZ. Hot Springs, AR. Arroyo Grande, CA. Duarte, CA. Sacramento, CA. Colorado Springs, CO. Denver, CO. Durango, CO.

• Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma

  Conditions:	Unresectable Pleural or Peritoneal Malignant Mesothelioma
  Last Updated:	July 2, 2019
  Status:	Active, not recruiting
  Locations:	Canton, OH. Scottsdale, AZ. La Jolla, CA. Los Angeles, CA. San Francisco, CA. Santa Monica, CA. New Haven, CT. Newark, DE. Tampa, FL. Augusta, GA.

• Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients

  Conditions:	Mesothelioma
  Last Updated:	July 1, 2019
  Status:	Active, not recruiting
  Locations:	Cleveland, OH. San Francisco, CA. New Haven, CT. Tampa, FL. Chicago, IL. Baltimore, MD. Detroit, MI. Grand Rapids, MI. Rochester, MN. New York, NY.

• Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

  Conditions:	Malignant Pleural Mesothelioma
  Last Updated:	June 26, 2019
  Status:	Recruiting
  Locations:	Toledo, OH. Los Angeles, CA. Tampa, FL. Baltimore, MD. New York, NY.

Ohio Cancer Support Services

The following cancer support services may be of help to you while you are receiving treatment for mesothelioma in Ohio. Support services for mesothelioma patients include patient transport, temporary housing, physical therapy and counseling.

Connect With a 13-Year Mesothelioma Survivor

Heather Von St. James